Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Roberts

Showing results (231-240 of 252) with videos related to

Pageof 26
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)|November 18, 2025
Evaluation of self-mediated alternatives for risk testing education and return of results (eSMARTER) study: A randomized study of methods for returning <i>APOE</i> and pTau-217 resultsClaire M Erickson, Carolyn M Langlois, Elisabeth McCarty Wood, et al.
The Journal of Clinical Endocrinology and Metabolism|May 9, 2022
Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked HypophosphatemiaLeanne M Ward, Francis H Glorieux, Michael P Whyte, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
The Association of the Microbiome with Melanoma Tumor Response to Immune Checkpoint Inhibitor Treatment and Immune-Related Adverse Events (NCT05102773)Caroline Dravillas, Nyelia Williams, Marium Husain, et al.
Annals of Internal Medicine|January 27, 2016
Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized TrialKurt D Christensen, J Scott Roberts, Peter J Whitehouse, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 27, 2020
Disclosing genetic risk for Alzheimer's dementia to individuals with mild cognitive impairmentKurt D Christensen, Jason Karlawish, J Scott Roberts, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerationsMichael M Witte, Norman L Foster, Adam S Fleisher, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 16, 2024
Nephrocalcinosis and kidney function in children and adults with X-linked hypophosphatemia: baseline results from a large longitudinal studyAnthony A Portale, Leanne Ward, Kathryn Dahir, et al.
Alzheimer Disease and Associated Disorders|March 5, 2008
Children of persons with Alzheimer disease: what does the future hold?Lissy Jarvik, Asenath LaRue, Deborah Blacker, et al.
The Lancet. Healthy Longevity|November 30, 2025
Impact of learning APOE genotype on cognitively unimpaired adults: a pre-screening cohort study of the Alzheimer's Prevention Initiative Generation Study 1Jessica B Langbaum, Angela R Bradbury, Brian L Egleston, et al.
The Journal of Clinical Endocrinology and Metabolism|April 21, 2023
Burosumab vs Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Subgroup Analysis by Dose LevelErik A Imel, Francis H Glorieux, Michael P Whyte, et al.
Pageof 26

Showing results (231-240 of 252) with videos related to

Sort By:
Pageof 26
Alzheimer'S & Dementia (New York, N. Y.)|November 18, 2025
Evaluation of self-mediated alternatives for risk testing education and return of results (eSMARTER) study: A randomized study of methods for returning <i>APOE</i> and pTau-217 resultsClaire M Erickson, Carolyn M Langlois, Elisabeth McCarty Wood, et al.
The Journal of Clinical Endocrinology and Metabolism|May 9, 2022
Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked HypophosphatemiaLeanne M Ward, Francis H Glorieux, Michael P Whyte, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
The Association of the Microbiome with Melanoma Tumor Response to Immune Checkpoint Inhibitor Treatment and Immune-Related Adverse Events (NCT05102773)Caroline Dravillas, Nyelia Williams, Marium Husain, et al.
Annals of Internal Medicine|January 27, 2016
Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized TrialKurt D Christensen, J Scott Roberts, Peter J Whitehouse, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 27, 2020
Disclosing genetic risk for Alzheimer's dementia to individuals with mild cognitive impairmentKurt D Christensen, Jason Karlawish, J Scott Roberts, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerationsMichael M Witte, Norman L Foster, Adam S Fleisher, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 16, 2024
Nephrocalcinosis and kidney function in children and adults with X-linked hypophosphatemia: baseline results from a large longitudinal studyAnthony A Portale, Leanne Ward, Kathryn Dahir, et al.
Alzheimer Disease and Associated Disorders|March 5, 2008
Children of persons with Alzheimer disease: what does the future hold?Lissy Jarvik, Asenath LaRue, Deborah Blacker, et al.
The Lancet. Healthy Longevity|November 30, 2025
Impact of learning APOE genotype on cognitively unimpaired adults: a pre-screening cohort study of the Alzheimer's Prevention Initiative Generation Study 1Jessica B Langbaum, Angela R Bradbury, Brian L Egleston, et al.
The Journal of Clinical Endocrinology and Metabolism|April 21, 2023
Burosumab vs Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Subgroup Analysis by Dose LevelErik A Imel, Francis H Glorieux, Michael P Whyte, et al.
Pageof 26